Press Releases

Press Releases

Bristol-Myers Squibb Company and QIMR Berghofer Medical Research Institute have signed a research collaboration and license agreement to discover novel therapeutic antibodies against an undisclosed immuno-oncology (I-O) target. “Bristol-Myers Squibb continues to invest in strategic partnerships that accelerate the discovery and development of novel immunotherapies through innovative science and technologies,”…

Press Releases

The shift from product to patient-centered practice in pharmacy is said to be a leading trend in the globe nowadays. The GCC region, believed by some experts to witness rapid developments in its pharmacy practice and education, is among those who are moving towards this trend. Dr. Lamia Yahya, Clinical…

Press Releases

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing entinostat as a combination therapy in multiple cancer indications, announced today that it has entered into a clinical collaboration with Genentech, a member of the Roche Group, to evaluate the safety, tolerability and preliminary efficacy of Syndax's entinostat, an oral…

Press Releases

Halo Pharmaceutical, a rapidly growing Contract Development and Manufacturing Organization (CDMO), is pleased to announce the appointments of Lee Karras as its Chief Executive Officer and Barry Lederman as its Chief Financial Officer. Lee Karras is an established pharmaceutical business executive with over twenty five years of healthcare industry related…

Press Releases

BioPharma Services Inc. is proud to announce that its Toronto-based Bioanalytical Laboratory has successfully passed its first inspection by the Brazilian regulatory authority, ANVISA. This inspection also included a Health Canada inspector as an observer. The inspection covered a comprehensive review of all laboratory procedures, systems and processes. The positive…

Press Releases

BioQuiddity Incorporated, a specialty pharmaceutical company focused on the development and commercialization of large volume ready-to-use infusible pharmaceuticals, and Lee’s Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm”, SEHK Stock Code: 0950), a biopharmaceutical company with over 20 years of operation in Asia, today announced…

Press Releases

Regeneron Pharmaceuticals Inc. has signed a nine-year lease expansion with BioMed Realty Trust Inc. for 116,200 square feet at the Landmark at Eastview, bringing the campus to more than 99 percent leased. The premier life sciences company now leases more than 1.1 million square feet at The Landmark at Eastview…

Press Releases

Honeywell Process Solutions (HPS) will showcase the latest developments in automation and process control at the Honeywell India Users Summit, Aug. 24 and 25 in Mumbai. More than 170 representatives from across process automation industries will attend the annual event. The summit will focus on issues facing manufacturers in India,…

Press Releases

Mylan N.V. today clarified certain inaccuracies by third parties related to Mylan having lowered the acceptance condition in its offer to acquire Perrigo Company plc (NYSE: PRGO; TASE) from not less than 80% of Perrigo ordinary shares to greater than 50% of Perrigo ordinary shares. Mylan Executive Chairman Robert J.…

Press Releases

OPKO Health, Inc. and Bio-Reference Laboratories, Inc. today announced the completion of the acquisition of Bio-Reference by OPKO. Shareholders of Bio-Reference will receive 2.75 shares of OPKO common stock for each share of Bio-Reference common stock.  "The acquisition of Bio-Reference is important for OPKO," commented Dr. Phillip Frost, OPKO's Chairman…